As chairman, CEO and president of Quest Diagnostics, the world’s largest provider of diagnostic information services, Rusckowski is in charge of the Secaucus-based lab’s nearly 50,000 employees who he says “responded as heroes to the COVID-19 pandemic” by developing COVID-19 tests, building test capacity, innovating new testing models with its retail partners, transporting specimens, delivering results and, of course, supporting its customers.
Ruskowski has also overseen the development of Quest’s new and most highly automated laboratory in its network that went live in January. The Clifton space will consolidate volumes from its Teterboro, Baltimore, and Philadelphia labs over the course of 2021.
Rusckowski said at a March 11 virtual Investor Day meeting with analysts and investors that some of the recent COVID-19 and base business testing trends as well as initiatives underway the company is planning to accelerate its growth include taking advantage of expanded access to 90% of commercially insured lives across the U.S.; strengthening the company’s relationships with hospital health systems; increasing market share in advanced diagnostics through innovation; building on the company’s growth in consumer testing; and supporting return to work, school and life activities with COVID-19 testing.
Before leading Quest, Rusckowski was CEO of Philips Healthcare, the largest unit of Royal Philips Electronics. During his time with Philips, revenues increased from approximately 6 billion euros in 2005 to approximately 9 billion euros in 2011, accounting for approximately 39% of Philips consolidated revenues, from 21% when he became CEO. Before joining Philips, Rusckowski held numerous management positions with the health care division of Hewlett-Packard/Agilent Technologies. He joined Philips when it acquired Agilent’s Healthcare Solutions Group in 2001.
